24/7 Market News Snapshot 17 June, 2025 – Processa Pharmaceuticals, Inc. Common (NASDAQ:PCSA)

June 17, 2025

DENVER, Colo., 17 June, 2025 (www.247marketnews.com) – (NASDAQ:PCSA) are discussed in this article.
Processa Pharmaceuticals, Inc., a clinical-stage company focused on Next Generation Cancer (NGC) therapies, is witnessing notable market activity following the announcement of a public offering. The company has priced 28 million shares of common stock along with associated warrants at $0.25 per share. This offering is anticipated to raise approximately $7 million, net of placement agent fees and expenses, and is expected to close around June 18, 2025, subject to customary conditions.

As shares opened today at $0.587 and fluctuated to a current trading price of $0.284, reflecting a 26.17% increase from the previous day’s close of $0.225, investor interest is evidently high. With a trading volume soaring to 463.96 million shares, stakeholders are actively participating in this dynamic market environment.

H.C. Wainwright & Co. is acting as the exclusive placement agent for this offering, which will facilitate the continued development of the Phase 2 clinical trial for Processa’s groundbreaking therapy, NCG-Cap. The company’s innovative approach aims to enhance the efficacy and safety of existing FDA-approved oncology treatments, thus providing patients with better-tolerated therapy options. By optimizing the metabolism and distribution of these drugs while maintaining their effectiveness, Processa is dedicated to pioneering advancements in cancer care.

The registration statement for this offering has been declared effective by the Securities and Exchange Commission (SEC), with additional information to be made available in a prospectus accessible through the SEC’s website. As Processa navigates this promising phase, the industry looks forward to the impactful developments that this funding will enable, further elevating the standards in oncology treatment and patient care.

Related news for (PCSA)

NASDAQ and NYSE quotes and data are delayed 15 minutes unless indicated otherwise. Market data and exchange information are provided for informational purposes only and is not intended for trading purposes. Neither 24/7 Market News Editors, 247 Market News, or data and content providers shall be liable for any errors or omissions, delays, misquotes or other market information relayed in any press materials. You should Use Realtime data to conduct due diligence before investing or trading, and trading in any stock is risky you could lose all your money.